by Karen O'Hanlon Cohrt | Dec 17, 2018 | Industry News
The increasing complexity of novel therapies calls for disease models that take us closer than ever before to the in vivo situation, to maximize efficacy and safety evaluations of new experimental treatments. Significant improvements in our understanding of mammalian...
